DataMeds AI Inc. is shifting resources toward commercializing ChemoFx after acquiring Pittsburgh-based Helomics in September.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.